If you treat severe COPD, bronchoscopic lung volume reduction (BLVR) using endobronchial valves is an option you should be discussing with your patients. This webinar will help you identify which patients are likely to benefit from this nondrug, nonsurgical option. Clinical evidence from four randomized, controlled clinical trials, including the risks and benefits, will be reviewed. Endobronchial valves are now included in most treatment guidelines (including GOLD: Evidence Level A) and have been clinically proven to improve lung function, exercise capacity, and quality of life in patients with severe emphysema. Come learn more about this life-changing therapy. At the conclusion of the presentation, there will be an opportunity for an interactive question and answer session with our faculty.
